- Home
- NNBR vs ASRT Comparison
NNBR vs ASRT Comparison
Compare NNBR & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NNBR | ASRT |
|---|---|---|
| Founded | 1980 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.7M | 75.1M |
| IPO Year | 1994 | 1997 |
Fundamental Metrics
Financial Performance| Metric | NNBR | ASRT |
|---|---|---|
| Price | $1.18 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 541.4K | 313.9K |
| Earning Date | 10-29-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $424,005,000.00 | $137,354,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.31 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.22 |
| 52 Week Low | $1.10 | $0.51 |
| 52 Week High | $4.67 | $1.01 |
Technical Indicators
Market Signals| Indicator | NNBR | ASRT |
|---|---|---|
| Relative Strength Index (RSI) | 35.66 | 41.47 |
| Support Level | $1.17 | $0.75 |
| Resistance Level | $1.24 | $0.80 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 20.03 | 23.22 |
Price Performance
Historical ComparisonAbout NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.